Nevada Psychiatric Association (NPA) - 23rd Annual Psychopharmacology Update Conference

Date
2018-02-14 - 2018-02-17
Exhibitors
0
Attendees
1500
Event contact title
Conference Manager
Event contact first name
Katie
Event contact last name
Bertini
Email
conferencemanager@nvpsychiatry.org
Event contact telephone number
702-749-7489
Description

The NPA Psychopharmacology Update is one of the nation’s largest conferences in the field, providing comprehensive state-of-the-art information on the psycho-pharmacological treatment of psychiatric disorders most commonly encountered in clinical practice.

Please join us for the Nevada Psychiatric Association’s 23rd Annual National Psychopharmacology Update over President’s Day weekend in Las Vegas! In addition to the annual three-day Psychopharmcology Update, we have planned one additional conference day – a Pre-Conference on Substance Use Disorders – for four days packed with educational sessions on the latest trends and treatment of psychiatric disorders essential to your practice.

As the largest psychopharmacology conference in the US, last year NPA hosted 1,500 attendees from 48 states and 8 countries!

Exhibitor information

Sponsors and exhibitors represent a range of leading industry partners and providers from across the United States in the areas of:

• Pharmaceutical products/services

• Medical/therapeutic devices

• Recruitment/Locum Tenens

• Training programs

• Medical and rehabilitation services

• Publishers and educational materials

• Practice management

• Support services

• Hospitals and treatment facilities

Partner Voices

Until recently, the opportunity to have a celebrity attend an event, attach themselves to a name-brand or endorse a certain product or idea was untouchable. The thought of paying a person to promote a product was seen as something only Fortune 500 companies could afford. Social media has changed all that with brands and businesses utilizing celebrity influencers to connect directly with their demographics and increase sales and profits.